A (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid DMF (Drug Master File) is a document detailing the whole manufacturing process of (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid active pharmaceutical ingredient (API) in detail. Different forms of (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid DMFs exist exist since differing nations have different regulations, such as (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid DMF submitted to regulatory agencies in the US is known as a USDMF. (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid USDMF includes data on (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (alphaS)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid suppliers with USDMF on PharmaCompass.